FindTrial
Sign In

Randomised trial of primary systemic therapy versus conventional therapy in operable breast cancer

Randomised trial of primary systemic therapy versus conventional therapy in operable breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN52587283
Enrollment
Unknown
Registered
2002-08-19
Start date
1990-01-01
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

1. Group A: Mastectomy, wide local excision and axillary clearance plus adjuvant tamoxifen or CMF chemotherapy (depending on menstrual and nodal status) 2. Group B: Primary systemic th

Sponsors

Scottish Cancer Therapy Network (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Operable carcinoma of the breast 2. Age <70 years 3. No medical contraindications to protocol treatments

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026